Logos Global Management’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.7M | Hold |
3,208,875
| – | – | 1.51% | 21 |
|
|
2025
Q1 | $12.1M | Hold |
3,208,875
| – | – | 2.14% | 18 |
|
|
2024
Q4 | $18.7M | Hold |
3,208,875
| – | – | 2.19% | 17 |
|
|
2024
Q3 | $38.3M | Hold |
3,208,875
| – | – | 4.13% | 6 |
|
|
2024
Q2 | $34.7M | Sell |
3,208,875
-1,175,000
| -27% | -$12.7M | 2.79% | 8 |
|
|
2024
Q1 | $49.6M | Hold |
4,383,875
| – | – | 4.02% | 6 |
|
|
2023
Q4 | $54.4M | Buy |
4,383,875
+640,000
| +17% | +$7.94M | 5.08% | 5 |
|
|
2023
Q3 | $46.2M | Hold |
3,743,875
| – | – | 6.17% | 3 |
|
|
2023
Q2 | $33.8M | Hold |
3,743,875
| – | – | 4.6% | 6 |
|
|
2023
Q1 | $13M | Hold |
3,743,875
| – | – | 1.86% | 23 |
|
|
2022
Q4 | $9.17M | Hold |
3,743,875
| – | – | 1.07% | 26 |
|
|
2022
Q3 | $10.3M | Hold |
3,743,875
| – | – | 1.27% | 22 |
|
|
2022
Q2 | $15.2M | Hold |
3,743,875
| – | – | 2.8% | 15 |
|
|
2022
Q1 | $15.9M | Hold |
3,743,875
| – | – | 2.07% | 20 |
|
|
2021
Q4 | $35M | Hold |
3,743,875
| – | – | 3.61% | 13 |
|
|
2021
Q3 | $103M | Hold |
3,743,875
| – | – | 7.44% | 2 |
|
|
2021
Q2 | $105M | Hold |
3,743,875
| – | – | 8.8% | 2 |
|
|
2021
Q1 | $124M | Hold |
3,743,875
| – | – | 12.12% | 2 |
|
|
2020
Q4 | $180M | Buy |
+3,743,875
| New | +$180M | 15.43% | 2 |
|